乳腺癌治疗相关肺损伤诊治共识

2020-07-30 中国肿瘤科相关专家小组(统称) 癌症进展.2020.18(14):1405-1412.

肺损伤是乳腺癌放、化疗及靶向治疗中非常重要的不良反应,因病情的复杂性及多变性,往往不能及时诊治甚至危及患者的生命,严重影响患者的预后及生活质量。放化疗及靶向治疗导致肺损伤的机制及相关因素尚不完全清楚。

中文标题:

乳腺癌治疗相关肺损伤诊治共识

发布日期:

2020-07-30

简要介绍:

肺损伤是乳腺癌放、化疗及靶向治疗中非常重要的不良反应,因病情的复杂性及多变性,往往不能及时诊治甚至危及患者的生命,严重影响患者的预后及生活质量。放化疗及靶向治疗导致肺损伤的机制及相关因素尚不完全清楚。因此,如何预防、早期诊断及治疗乳腺癌治疗引起的肺损伤是临床治疗过程中不可忽略的一个问题。因此,本研究组组织了国内乳腺癌病理、影像、药学、放疗、内科及呼吸内科的专家,依据国际及国内的临床诊治经验和证据制定了本共识,旨在提高临床医师对乳腺癌治疗相关肺损伤的认识水平,规范其临床诊治,提倡早期筛查、及时确诊和规范治疗,重视患者随访与管理,最终改善患者的预后和生活质量。同时,本共识也提出了乳腺癌治疗相关肺损伤临床诊治和研究中若干尚不明确、有待解决的问题,期望通过建立多学科、多中心合作,开展相关临床和基础研究,不断积累研究证据,逐步达成共识。

相关资料下载:
[AttachmentFileName(sort=1, fileName=乳腺癌治疗相关肺损伤诊治共识_邵彬.pdf)] GetToolGuiderByIdResponse(projectId=1, id=4bc841c0019ea962, title=乳腺癌治疗相关肺损伤诊治共识, enTitle=, guiderFrom=癌症进展.2020.18(14):1405-1412., authorId=0, author=, summary=肺损伤是乳腺癌放、化疗及靶向治疗中非常重要的不良反应,因病情的复杂性及多变性,往往不能及时诊治甚至危及患者的生命,严重影响患者的预后及生活质量。放化疗及靶向治疗导致肺损伤的机制及相关因素尚不完全清楚。, cover=https://img.medsci.cn/2020923/1600871389009_2020535.jpg, journalId=0, articlesId=null, associationId=747, associationName=中国肿瘤科相关专家小组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Thu Jul 30 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>肺损伤是乳腺癌放、化疗及靶向治疗中非常重要的不良反应,因病情的复杂性及多变性,往往不能及时诊治甚至危及患者的生命,严重影响患者的预后及生活质量。放化疗及靶向治疗导致肺损伤的机制及相关因素尚不完全清楚。因此,如何预防、早期诊断及治疗乳腺癌治疗引起的肺损伤是临床治疗过程中不可忽略的一个问题。因此,本研究组组织了国内乳腺癌病理、影像、药学、放疗、内科及呼吸内科的专家,依据国际及国内的临床诊治经验和证据制定了本共识,旨在提高临床医师对乳腺癌治疗相关肺损伤的认识水平,规范其临床诊治,提倡早期筛查、及时确诊和规范治疗,重视患者随访与管理,最终改善患者的预后和生活质量。同时,本共识也提出了乳腺癌治疗相关肺损伤临床诊治和研究中若干尚不明确、有待解决的问题,期望通过建立多学科、多中心合作,开展相关临床和基础研究,不断积累研究证据,逐步达成共识。</p> </div> </div> </div>, tagList=[TagDto(tagId=285, tagName=乳腺癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=89, categoryName=乳腺癌, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=285, guiderKeyword=乳腺癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7626, appHits=187, showAppHits=0, pcHits=490, showPcHits=7439, likes=0, shares=19, comments=22, approvalStatus=1, publishedTime=Wed Sep 23 23:08:53 CST 2020, publishedTimeString=2020-07-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed Sep 23 22:29:57 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 10:44:02 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=乳腺癌治疗相关肺损伤诊治共识_邵彬.pdf)])
乳腺癌治疗相关肺损伤诊治共识_邵彬.pdf
下载请点击:
评论区 (12)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1079014, encodeId=5baf10e901476, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d81e2801105, createdName=1020235510, createdTime=Sat Dec 11 10:54:07 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014667, encodeId=32ef101466e54, content=受用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=921e5587685, createdName=ms6000001140119588, createdTime=Sun Sep 05 00:43:26 CST 2021, time=2021-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977163, encodeId=3ffe9e7163aa, content=想学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210626/11584159ef9b48fb826a931627f16db0/8c4cc49a51c543e7bd5b0ce7cd20fa18.jpg, createdBy=0eea5533600, createdName=花卷卷, createdTime=Sat Jun 26 22:59:15 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976803, encodeId=77829e68039d, content=经历过, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210625/db72c2404faf490084574ea0ff26a314/ff6e3f5731ee4f8da077ff4fa96a9490.jpg, createdBy=14a72181754, createdName=Monica_jojo, createdTime=Fri Jun 25 14:46:13 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916052, encodeId=8dd39160523f, content=一旦发生严重肺部问题,处理难度大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ebe5452280, createdName=ms4000001265123660, createdTime=Tue Jan 12 21:34:38 CST 2021, time=2021-01-12, status=1, ipAttribution=)]
    2021-12-11 1020235510

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1079014, encodeId=5baf10e901476, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d81e2801105, createdName=1020235510, createdTime=Sat Dec 11 10:54:07 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014667, encodeId=32ef101466e54, content=受用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=921e5587685, createdName=ms6000001140119588, createdTime=Sun Sep 05 00:43:26 CST 2021, time=2021-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977163, encodeId=3ffe9e7163aa, content=想学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210626/11584159ef9b48fb826a931627f16db0/8c4cc49a51c543e7bd5b0ce7cd20fa18.jpg, createdBy=0eea5533600, createdName=花卷卷, createdTime=Sat Jun 26 22:59:15 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976803, encodeId=77829e68039d, content=经历过, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210625/db72c2404faf490084574ea0ff26a314/ff6e3f5731ee4f8da077ff4fa96a9490.jpg, createdBy=14a72181754, createdName=Monica_jojo, createdTime=Fri Jun 25 14:46:13 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916052, encodeId=8dd39160523f, content=一旦发生严重肺部问题,处理难度大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ebe5452280, createdName=ms4000001265123660, createdTime=Tue Jan 12 21:34:38 CST 2021, time=2021-01-12, status=1, ipAttribution=)]
    2021-09-05 ms6000001140119588

    受用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1079014, encodeId=5baf10e901476, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d81e2801105, createdName=1020235510, createdTime=Sat Dec 11 10:54:07 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014667, encodeId=32ef101466e54, content=受用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=921e5587685, createdName=ms6000001140119588, createdTime=Sun Sep 05 00:43:26 CST 2021, time=2021-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977163, encodeId=3ffe9e7163aa, content=想学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210626/11584159ef9b48fb826a931627f16db0/8c4cc49a51c543e7bd5b0ce7cd20fa18.jpg, createdBy=0eea5533600, createdName=花卷卷, createdTime=Sat Jun 26 22:59:15 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976803, encodeId=77829e68039d, content=经历过, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210625/db72c2404faf490084574ea0ff26a314/ff6e3f5731ee4f8da077ff4fa96a9490.jpg, createdBy=14a72181754, createdName=Monica_jojo, createdTime=Fri Jun 25 14:46:13 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916052, encodeId=8dd39160523f, content=一旦发生严重肺部问题,处理难度大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ebe5452280, createdName=ms4000001265123660, createdTime=Tue Jan 12 21:34:38 CST 2021, time=2021-01-12, status=1, ipAttribution=)]
    2021-06-26 花卷卷

    想学习一下

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1079014, encodeId=5baf10e901476, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d81e2801105, createdName=1020235510, createdTime=Sat Dec 11 10:54:07 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014667, encodeId=32ef101466e54, content=受用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=921e5587685, createdName=ms6000001140119588, createdTime=Sun Sep 05 00:43:26 CST 2021, time=2021-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977163, encodeId=3ffe9e7163aa, content=想学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210626/11584159ef9b48fb826a931627f16db0/8c4cc49a51c543e7bd5b0ce7cd20fa18.jpg, createdBy=0eea5533600, createdName=花卷卷, createdTime=Sat Jun 26 22:59:15 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976803, encodeId=77829e68039d, content=经历过, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210625/db72c2404faf490084574ea0ff26a314/ff6e3f5731ee4f8da077ff4fa96a9490.jpg, createdBy=14a72181754, createdName=Monica_jojo, createdTime=Fri Jun 25 14:46:13 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916052, encodeId=8dd39160523f, content=一旦发生严重肺部问题,处理难度大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ebe5452280, createdName=ms4000001265123660, createdTime=Tue Jan 12 21:34:38 CST 2021, time=2021-01-12, status=1, ipAttribution=)]
    2021-06-25 Monica_jojo

    经历过

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1079014, encodeId=5baf10e901476, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d81e2801105, createdName=1020235510, createdTime=Sat Dec 11 10:54:07 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014667, encodeId=32ef101466e54, content=受用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=921e5587685, createdName=ms6000001140119588, createdTime=Sun Sep 05 00:43:26 CST 2021, time=2021-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977163, encodeId=3ffe9e7163aa, content=想学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210626/11584159ef9b48fb826a931627f16db0/8c4cc49a51c543e7bd5b0ce7cd20fa18.jpg, createdBy=0eea5533600, createdName=花卷卷, createdTime=Sat Jun 26 22:59:15 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976803, encodeId=77829e68039d, content=经历过, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210625/db72c2404faf490084574ea0ff26a314/ff6e3f5731ee4f8da077ff4fa96a9490.jpg, createdBy=14a72181754, createdName=Monica_jojo, createdTime=Fri Jun 25 14:46:13 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916052, encodeId=8dd39160523f, content=一旦发生严重肺部问题,处理难度大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ebe5452280, createdName=ms4000001265123660, createdTime=Tue Jan 12 21:34:38 CST 2021, time=2021-01-12, status=1, ipAttribution=)]
    2021-01-12 ms4000001265123660

    一旦发生严重肺部问题,处理难度大

    0

拓展阅读

乳腺癌HER2检测指南(2009版)

中国肿瘤科相关专家小组(统称) · 2009-12-01

2010 乳腺癌骨转移和骨相关疾病临床诊疗专家共识(2010版)

乳腺癌骨转移和骨相关疾病临床诊疗专家组 · 2010-01-01

2010 SBI/ACR推荐建议:乳腺癌影像学筛查

乳腺影像学会(SBI,Society of Breast Imaging) · 2010-01-20

2010 人表皮生长因子受体2阳性乳腺癌临床诊疗专家共识

中国抗癌协会乳腺癌专业委员会(CACA-CBCS,Chinese Anti-Cancer Association, Committee of Breast Cancer Society) · 2010-02-01

2010 ASCO-CAP指南:乳腺癌患者雌激素和雄激素受体的免疫组化检测

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2010-04-19

2010 ASCO指南:激素受体阳性乳腺癌妇女的辅助内分泌治疗

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2010-07-12